Therapy of Relapsed AML With Chemotherapy and Dendritic Cell Activated Lymphocytes

This study has been withdrawn prior to enrollment.

(Slow accrual.)

Sponsor:

Collaborators:

Immunex Corporation

Information provided by (Responsible Party):

M.D. Anderson Cancer Center

ClinicalTrials.gov Identifier:

NCT00038870

First received: June 5, 2002

Last updated: August 2, 2012

Last verified: August 2012

No Study Results Posted on ClinicalTrials.gov for this Study

Study was withdrawn before participants were enrolled.

Study Status:	This study has been withdrawn prior to enrollment.
Study Completion Date:	January 2003
Primary Completion Date:	January 2003 (Final data collection date for primary outcome measure)